Skip to main content
logo
The Weir Group PLC (LON:WEIR)
London flag London · Delayed Price · Currency is GBP · Price in GBp
2,492.00
+8.00 (0.32%)
Aug 8, 2025, 5:03 PM BST

Inozyme Pharma Revenue

The Weir Group had revenue of 1.19B GBP in the half year ending June 30, 2025, a decrease of -8.08%. This brings the company's revenue in the last twelve months to 2.49B, down -3.73% year-over-year. In the year 2024, The Weir Group had annual revenue of 2.51B, down -4.95%.

Revenue (ttm)
2.49B
Revenue Growth
-3.73%
P/S Ratio
2.57
Revenue / Employee
217.86K
Employees
11,444
Market Cap
6.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.51B-130.40M-4.95%
Dec 31, 20232.64B163.90M6.63%
Dec 31, 20222.47B538.50M27.85%
Dec 31, 20211.93B-31.10M-1.58%
Dec 31, 20201.96B-85.10M-4.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Jan 1, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rolls-Royce Holdings19.54B
RELX PLC9.53B
BAE Systems27.41B
Experian5.82B
Ashtead Group8.09B
International Consolidated Airlines Group28.53B
Halma2.25B
Rentokil Initial5.53B
Revenue Rankings

The Weir Group News

More News